...
机译:紫杉烷和蒽环类组合方案在晚期乳腺癌管理中的作用荟萃分析随机试验
Southern Med Univ Zhujiang Hosp Dept Oncol Guangzhou 510282 Guangdong Peoples R China;
Southern Med Univ Zhujiang Hosp Dept Gen Surg Guangzhou 510282 Guangdong Peoples R China;
Southern Med Univ Dept Stat Guangzhou 510282 Guangdong Peoples R China;
Southern Med Univ Zhujiang Hosp Dept Oncol Guangzhou 510282 Guangdong Peoples R China;
Dongguan Peoples Hosp Dept Oncol Dongguan Peoples R China;
Dongguan Peoples Hosp Dept Oncol Dongguan Peoples R China;
Dongguan Peoples Hosp Dept Oncol Dongguan Peoples R China;
Lib Southern Med Univ Guangzhou Guangdong Peoples R China;
Second Peoples Hosp Shenzhen City Dept Oncol Shenzhen Peoples R China;
Guangzhou Med Univ Dept Internal Med Affiliated Canc Hosp Guangzhou Guangdong Peoples R China;
Southern Med Univ Zhujiang Hosp Dept Oncol Guangzhou 510282 Guangdong Peoples R China;
机译:紫杉烷和蒽环类联合用药方案在晚期乳腺癌管理中的作用一项随机试验的荟萃分析
机译:每周紫杉烷-蒽环类药物联合方案与三周基于蒽环类药物的方案治疗局部晚期乳腺癌的随机对照试验
机译:每周紫杉烷-蒽环类药物联合方案与三周基于蒽环类药物的方案治疗局部晚期乳腺癌的随机对照试验
机译:HER-2和P53在紫杉烷基和蒽环类新辅助化疗的乳腺癌中的临床意义
机译:MCF-7乳腺癌细胞在对紫杉烷和蒽环类药物的耐药性选择中的基因组反应。
机译:每周紫杉烷-蒽环类药物联合方案与三周基于蒽环类药物的方案治疗局部晚期乳腺癌的随机对照试验
机译:每周紫杉烷-蒽环类药物联合方案与三周基于蒽环类药物的方案治疗局部晚期乳腺癌的随机对照试验